The Role of Intravitreal Corticosteroids in the Treatment of DME : Predictive OCT Biomarkers
Contributeurs/tricesMunk, Marion R![orcid](assets/images/orcid.png)
; Somfai, Gabor Mark![orcid](assets/images/orcid.png)
; de Smet, Marc D![orcid](assets/images/orcid.png)
; Donati, Guy; Menke, Marcel N; Garweg, Justus G![orcid](assets/images/orcid.png)
; Ceklic, Lala
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
Publié dansInternational journal of molecular sciences, vol. 23, no. 14, 7585
Date de publication2022-07-08
Date de mise en ligne2022-07-08
Résumé
Mots-clés
- DME
- OCT
- Anti-VEGF
- Biomarker
- Corticosteroid
- Dexamethasone
- Diabetes mellitus
- Diabetic macular edema
- Diabetic maculopathy
- Response to treatment
- Adrenal Cortex Hormones / therapeutic use
- Angiogenesis Inhibitors / therapeutic use
- Biomarkers
- Diabetic Retinopathy / drug therapy
- Humans
- Intravitreal Injections
- Macular Edema / drug therapy
- Retrospective Studies
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A / therapeutic use
Structure d'affiliation
Citation (format ISO)
MUNK, Marion R et al. The Role of Intravitreal Corticosteroids in the Treatment of DME : Predictive OCT Biomarkers. In: International journal of molecular sciences, 2022, vol. 23, n° 14, p. 7585. doi: 10.3390/ijms23147585
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:173761
- DOI : 10.3390/ijms23147585
- PMID : 35886930
- PMCID : PMC9319632
ISSN du journal1422-0067